Skip to main content
AAN.com
Research Articles
July 27, 2022

Association of Ultraprocessed Food Consumption With Risk of Dementia
A Prospective Cohort Study

September 6, 2022 issue
99 (10) e1056-e1066

Abstract

Background and Objectives

There has been a growing body of evidence associating consumption of ultraprocessed foods (UPF) with adverse health outcomes including depression, cardiovascular disease, and all-cause mortality. However, whether UPF are associated with dementia is unknown. The authors investigated the associations between UPF and dementia incidence in the UK Biobank.

Methods

We included 72,083 participants (55 years or older) who were free from dementia at baseline and provided at least 2 times 24-hour dietary assessments from the UK Biobank study. Follow-up occurred through March 2021. UPF were defined according to the NOVA classification. Incident all-cause dementia comprising Alzheimer disease (AD) and vascular dementia was ascertained through electronic linkages to hospital and mortality records. Cox proportional hazards were used to estimate the association between the proportion (%) of UPF in the diet and the subsequent risk of dementia. In addition, substitution analysis was used to estimate the risk of dementia when substituting UPF with an equivalent proportion of unprocessed or minimally processed foods.

Results

During a total of 717,333 person-years of follow-up (median 10.0 years), 518 participants developed dementia, of whom 287 developed AD and 119 developed vascular dementia. In the fully adjusted model, consumption of UPF was associated with higher risk of dementia (hazard ratio [HR] for 10% increase in UPF 1.25; 95% CI 1.14–1.37), AD (HR 1.14; 95% CI 1.00–1.30), and vascular dementia (HR 1.28; 95% CI 1.06–1.55), respectively. In addition, replacing 10% of UPF weight in diet with an equivalent proportion of unprocessed or minimally processed foods was estimated to be associated with a 19% lower risk of dementia (HR 0.81; 95% CI 0.74–0.89).

Discussion

In this prospective cohort study, higher consumption of UPF was associated with higher risk of dementia, whereas substituting unprocessed or minimally processed foods for UPF was associated with lower risk of dementia.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673-2734.
2.
Alzheimer's Disease International. World Alzheimer Report 2015: The Global Impact of Dementia. ADI; 2015.
3.
World Health Organization. Global Health Estimates 2016: Disease Burden by Cause, Age, Sex, by Country and by Region, 2000–2016. WHO; 2018.
4.
Szeto JY, Lewis SJ. Current treatment options for Alzheimer's disease and Parkinson's disease dementia. Curr Neuropharmacol. 2016;14(4):326-338.
5.
Waterlander WE, de Haas WE, van Amstel I, et al. Energy density, energy costs and income—how are they related? Public Health Nutr. 2010;13(10):1599-1608.
6.
Martinez Steele E, Baraldi LG, Louzada ML, Moubarac JC, Mozaffarian D, Monteiro CA. Ultra-processed foods and added sugars in the US diet: evidence from a nationally representative cross-sectional study. BMJ Open. 2016;6(3):e009892.
7.
Monteiro CA, Moubarac JC, Cannon G, Ng SW, Popkin B. Ultra-processed products are becoming dominant in the global food system. Obes Rev. 2013;14(suppl 2):21-28.
8.
Fiolet T, Srour B, Sellem L, et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort. BMJ. 2018;360:k322.
9.
Srour B, Fezeu LK, Kesse-Guyot E, et al. Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé). BMJ. 2019;365:l1451.
10.
Louzada ML, Martins AP, Canella DS, et al. Impact of ultra-processed foods on micronutrient content in the Brazilian diet. Rev Saude Publica. 2015;49:45.
11.
Liu YH, Gao X, Na M, Kris-Etherton PM, Mitchell DC, Jensen GL. Dietary pattern, diet quality, and dementia: a systematic review and meta-analysis of prospective cohort studies. J Alzheimers Dis. 2020;78(1):151-168.
12.
Ni Y, Hu L, Yang S, et al. Bisphenol A impairs cognitive function and 5-HT metabolism in adult male mice by modulating the microbiota-gut-brain axis. Chemosphere. 2021;282:130952.
13.
Tabara Y, Yamanaka M, Setoh K, et al. Advanced glycation end product accumulation is associated with lower cognitive performance in an older general population: the Nagahama study. J Alzheimers Dis. 2020;74(3):741-746.
14.
Levy RB, Rauber F, Chang K, et al. Ultra-processed food consumption and type 2 diabetes incidence: a prospective cohort study. Clin Nutr. 2021;40(5):3608-3614.
15.
Srour B, Fezeu LK, Kesse-Guyot E, et al. Ultraprocessed food consumption and risk of type 2 diabetes among participants of the NutriNet-Santé prospective cohort. JAMA Intern Med. 2020;180(2):283-291.
16.
Rico-Campa A, Martinez-Gonzalez MA, Alvarez-Alvarez I, et al. Association between consumption of ultra-processed foods and all cause mortality: SUN prospective cohort study. BMJ. 2019;365:l1949.
17.
Galante J, Adamska L, Young A, et al. The acceptability of repeat Internet-based hybrid diet assessment of previous 24-h dietary intake: administration of the Oxford WebQ in UK Biobank. Br J Nutr. 2016;115(4):681-686.
18.
Greenwood DC, Hardie LJ, Frost GS, et al. Validation of the Oxford WebQ online 24-hour dietary questionnaire using biomarkers. Am J Epidemiol. 2019;188(10):1858-1867.
19.
Ministry of Agriculture, Fisheries and Food. Food Portion Sizes. 2nd ed. HMSO; 1993.
20.
Monteiro CA, Cannon G, Levy RB, et al. Ultra-processed foods: what they are and how to identify them. Public Health Nutr. 2019;22(5):936-941.
21.
Sleegers K, Bettens K, De Roeck A, et al. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Abeta42. Alzheimers Dement. 2015;11(12):1452-1460.
22.
Wolters FJ, van der Lee SJ, Koudstaal PJ, et al. Parental family history of dementia in relation to subclinical brain disease and dementia risk. Neurology. 2017;88(17):1642-1649.
23.
Wang M, Zhou T, Li X, et al. Baseline vitamin D status, sleep patterns, and the risk of incident type 2 diabetes in data from the UK biobank study. Diabetes Care. 2020;43(11):2776-2784.
24.
Pazoki R, Dehghan A, Evangelou E, et al. Genetic predisposition to high blood pressure and lifestyle factors: associations with midlife blood pressure levels and cardiovascular events. Circulation. 2018;137(7):653-661.
25.
Lavie CJ, Ozemek C, Kachur S. Promoting physical activity in primary and secondary prevention. Eur Heart J. 2019;40(43):3556-3558.
26.
Health and Deprivation P Townsend P Phillimore A Beattie Health and Deprivation Published by Croom Helm 212pp pound19.95 0-7099-4351-2 [Formula: see text]. Nurs Stand. 1988;2(17):34.
27.
Lyall DM, Cullen B, Allerhand M, et al. Cognitive test scores in UK biobank: data reduction in 480,416 participants and longitudinal stability in 20,346 participants. PLoS One. 2016;11(4):e0154222.
28.
Song M, Giovannucci E. Substitution analysis in nutritional epidemiology: proceed with caution. Eur J Epidemiol. 2018;33(2):137-140.
29.
Yuan Y. Multiple imputation using SAS software. J Stat Softw. 2011;45(6):1-25.
30.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
31.
Miao H, Chen K, Yan X, Chen F. Sugar in beverage and the risk of incident dementia, Alzheimer's disease and stroke: a prospective cohort study. J Prev Alzheimers Dis. 2021;8(2):188-193.
32.
Pase MP, Himali JJ, Beiser AS, et al. Sugar- and artificially sweetened beverages and the risks of incident stroke and dementia: a prospective cohort study. Stroke. 2017;48(5):1139-1146.
33.
Zhang H, Greenwood DC, Risch HA, Bunce D, Hardie LJ, Cade JE. Meat consumption and risk of incident dementia: cohort study of 493,888 UK Biobank participants. Am J Clin Nutr. 2021;114(1):175-184.
34.
Adjibade M, Julia C, Allès B, et al. Prospective association between ultra-processed food consumption and incident depressive symptoms in the French NutriNet-Santé cohort. BMC Med. 2019;17(1):78.
35.
Rauber F, Chang K, Vamos EP, et al. Ultra-processed food consumption and risk of obesity: a prospective cohort study of UK Biobank. Eur J Nutr. 2021;60(4):2169-2180.
36.
Romero Ferreiro C, Martin-Arriscado Arroba C, Cancelas Navia P, Lora Pablos D, Gomez de la Camara A. Ultra-processed food intake and all-cause mortality: DRECE cohort study. Public Health Nutr. 2021;2021:1-28.
37.
Guerville M, Leroy A, Sinquin A, Laugerette F, Michalski MC, Boudry G. Western-diet consumption induces alteration of barrier function mechanisms in the ileum that correlates with metabolic endotoxemia in rats. Am J Physiol Endocrinol Metab. 2017;313(2):E107-E120.
38.
Lopez-Moreno J, Garcia-Carpintero S, Jimenez-Lucena R, et al. Effect of dietary lipids on endotoxemia influences postprandial inflammatory response. J Agric Food Chem. 2017;65(35):7756-7763.
39.
Sankowski R, Mader S, Valdés-Ferrer SI. Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci. 2015;9:28.
40.
Guo CP, Wei Z, Huang F, et al. High salt induced hypertension leads to cognitive defect. Oncotarget. 2017;8(56):95780-95790.
41.
Mohan D, Yap KH, Reidpath D, et al. Link between dietary sodium intake, cognitive function, and dementia risk in middle-aged and older adults: a systematic review. J Alzheimers Dis. 2020;76(4):1347-1373.
42.
Zhou Y, Wang Z, Xia M, et al. Neurotoxicity of low bisphenol A (BPA) exposure for young male mice: implications for children exposed to environmental levels of BPA. Environ Pollut. 2017;229:40-48.
43.
Sharma C, Kaur A, Thind SS, Singh B, Raina S. Advanced glycation End-products (AGEs): an emerging concern for processed food industries. J Food Sci Technol. 2015;52(12):7561-7576.
44.
Vicente Miranda H, El-Agnaf OM, Outeiro TF. Glycation in Parkinson's disease and Alzheimer's disease. Mov Disord. 2016;31(6):782-790.
45.
Barbiellini Amidei C, Fayosse A, Dumurgier J, et al. Association between age at diabetes onset and subsequent risk of dementia. JAMA. 2021;325:1640-1649.
46.
Rothman KJ, Gallacher JE, Hatch EE. Why representativeness should be avoided. Int J Epidemiol. 2013;42(4):1012-1014.
47.
Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341-353.

Information & Authors

Information

Published In

Neurology®
Volume 99Number 10September 6, 2022
Pages: e1056-e1066
PubMed: 36219796

Publication History

Received: December 27, 2021
Accepted: May 5, 2022
Published online: July 27, 2022
Published in issue: September 6, 2022

Permissions

Request permissions for this article.

Disclosure

The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

Study Funding

This study was funded by the National Natural Science Foundation of China (No. 91746205).

Authors

Affiliations & Disclosures

Huiping Li, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Shu Li, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Hongxi Yang, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Yuan Zhang, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Shunming Zhang, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Yue Ma, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Yabing Hou, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Xinyu Zhang, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kaijun Niu, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Yan Borné, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Yaogang Wang, PhD
From the School of Public Health (H.L., H.Y., Y.Z., S.Z., Y.M., Y.H., X.Z., K.N., Y.W.), Tianjin Medical University; School of Management (S.L.), Tianjin University of Traditional Chinese Medicine; and Department of Clinical Sciences in Malmö (Y.B.), Lund University, Sweden.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Wang [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Linda Hershey, MD, PhD, FAAN.
Previously published at SSRN doi: 10.2139/ssrn.3978652.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Higher Ultraprocessed Food Consumption Is Associated With Depression Persistence and Higher Risk of Depression Incidence in the Brazilian Longitudinal Study of Adult Health, Journal of the Academy of Nutrition and Dietetics, 125, 5, (630-640.e7), (2025).https://doi.org/10.1016/j.jand.2024.10.012
    Crossref
  2. Ultra-processed food consumption affects structural integrity of feeding-related brain regions independent of and via adiposity, npj Metabolic Health and Disease, 3, 1, (2025).https://doi.org/10.1038/s44324-025-00056-3
    Crossref
  3. Food for thought: The relationship between poor eating habits, delay discounting, and quality of life in substance use recovery, Eating Behaviors, 57, (101972), (2025).https://doi.org/10.1016/j.eatbeh.2025.101972
    Crossref
  4. Ultraprocessed Foods and Neuropsychiatric Outcomes: Putative Mechanisms, Nutrients, 17, 7, (1215), (2025).https://doi.org/10.3390/nu17071215
    Crossref
  5. The risk associated with ultra-processed food intake on depressive symptoms and mental health in older adults: a target trial emulation, BMC Medicine, 23, 1, (2025).https://doi.org/10.1186/s12916-025-04002-4
    Crossref
  6. Associations between degree of food processing and all-cause and cause-specific mortality: a multicentre prospective cohort analysis in 9 European countries, The Lancet Regional Health - Europe, 50, (101208), (2025).https://doi.org/10.1016/j.lanepe.2024.101208
    Crossref
  7. Multimorbidity patterns and influencing factors in older Chinese adults: a national population-based cross-sectional survey, Journal of Global Health, 15, (2025).https://doi.org/10.7189/jogh.15.04051
    Crossref
  8. Ultra-processed food consumption and risk of dementia and Alzheimer's disease: The Framingham Heart Study, The Journal of Prevention of Alzheimer's Disease, 12, 2, (100042), (2025).https://doi.org/10.1016/j.tjpad.2024.100042
    Crossref
  9. Toxicological mechanisms of carbon polymers in accelerating cognitive decline in Alzheimer’s disease, Journal of Advanced Research, (2025).https://doi.org/10.1016/j.jare.2025.02.017
    Crossref
  10. Foods, dietary patterns, and risk of vascular dementia: a systematic review, Nutrition & Metabolism, 21, 1, (2024).https://doi.org/10.1186/s12986-024-00880-2
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share